Intellipharmaceutics International Inc.
IPCIF · OTC
8/31/2023 | 5/31/2023 | 2/28/2023 | 11/30/2022 | |
|---|---|---|---|---|
| Market Cap | $2,647 | $1,986 | $1,655 | $2,316 |
| - Cash | $400 | $159 | $70 | $84 |
| + Debt | $2,218 | $2,244 | $2,299 | $2,326 |
| Enterprise Value | $4,466 | $4,070 | $3,884 | $4,559 |
| Revenue | $69 | $480 | $326 | $30 |
| % Growth | -85.7% | 47.1% | 999.5% | – |
| Gross Profit | -$805 | $446 | $275 | $30 |
| % Margin | -1,171.5% | 93% | 84.2% | 100% |
| EBITDA | -$1,747 | $9 | -$261 | -$408 |
| % Margin | -2,541.9% | 1.9% | -79.9% | -1,374.4% |
| Net Income | -$1,889 | -$54 | -$356 | -$875 |
| % Margin | -2,749.2% | -11.3% | -109% | -2,947% |
| EPS Diluted | -0.057 | -0.002 | -0.011 | -0.026 |
| % Growth | -3,468.8% | 85% | 59.5% | – |
| Operating Cash Flow | $241 | $90 | -$14 | -$196 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $241 | $90 | -$14 | -$196 |